Scott, J.A. et al. Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet 378, 1316-1323

Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya. ascott@ikilifi .org
The Lancet (Impact Factor: 45.22). 09/2011; 378(9799):1316-23. DOI: 10.1016/S0140-6736(11)60888-X
Source: PubMed

ABSTRACT Many investigators have suggested that malaria infection predisposes individuals to bacteraemia. We tested this hypothesis with mendelian randomisation studies of children with the malaria-protective phenotype of sickle-cell trait (HbAS).
This study was done in a defined area around Kilifi District Hospital, Kilifi, Kenya. We did a matched case-control study to identify risk factors for invasive bacterial disease, in which cases were children aged 3 months to 13 years who were admitted to hospital with bacteraemia between Sept 16, 1999, and July 31, 2002. We aimed to match two controls, by age, sex, location, and time of recruitment, for every case. We then did a longitudinal case-control study to assess the relation between HbAS and invasive bacterial disease as malaria incidence decreased. Cases were children aged 0-13 years who were admitted to hospital with bacteraemia between Jan 1, 1999, and Dec 31, 2007. Controls were born in the study area between Jan 1, 2006, and June 23, 2009. Finally, we modelled the annual incidence of bacteraemia against the community prevalence of malaria during 9 years with Poisson regression.
In the matched case-control study, we recruited 292 cases-we recruited two controls for 236, and one for the remaining 56. Sickle-cell disease, HIV, leucocyte haemozoin pigment, and undernutrition were positively associated with bacteraemia and HbAS was strongly negatively associated with bacteraemia (odds ratio 0·36; 95% CI 0·20-0·65). In the longitudinal case-control study, we assessed data from 1454 cases and 10,749 controls. During the study period, the incidence of admission to hospital with malaria per 1000 child-years decreased from 28·5 to 3·45, with a reduction in protection afforded by HbAS against bacteraemia occurring in parallel (p=0·0008). The incidence of hospital admissions for bacteraemia per 1000 child-years also decreased from 2·59 to 1·45. The bacteraemia incidence rate ratio associated with malaria parasitaemia was 6·69 (95% CI 1·31-34·3) and, at a community parasite prevalence of 29% in 1999, 62% (8·2-91) of bacteraemia cases were attributable to malaria.
Malaria infection strongly predisposes individuals to bacteraemia and can account for more than half of all cases of bacteraemia in malaria-endemic areas. Interventions to control malaria will have a major additional benefit by reducing the burden of invasive bacterial disease.
Wellcome Trust.

Download full-text


Available from: J Anthony Gerard Scott, Aug 27, 2015
1 Follower
  • Source
    • "of the hemolytic infection in order to avoid exacerbated heme toxicity . The greatest reduction in co - morbidity will undoubtedly come from public health measures to control or eliminate the hemolytic infections . Malaria control is already known to produce dramatic decreases in the population burden of NTS bacteremia ( Mackenzie et al . , 2010 ; Scott et al . , 2011 ) and all - cause child mortality ( Kleinschmidt et al . , 2009 ) . Control of Carrion ' s disease appears more challenging , and indications of expanding geographical distribution suggest that co - infections may remain a problem for the foreseeable future ( Minnick et al . , 2014 ) ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Increased susceptibility to co-infection with enteric Gram-negative bacteria, particularly non-typhoidal Salmonella, is reported in malaria and Oroya fever (Bartonella bacilliformis infection), and can lead to increased mortality. Accumulating epidemiological evidence indicates a causal association with risk of bacterial co-infection, rather than just co-incidence of common risk factors. Both malaria and Oroya fever are characterized by hemolysis, and observations in humans and animal models suggest that hemolysis causes the susceptibility to bacterial co-infection. Evidence from animal models implicates hemolysis in the impairment of a variety of host defense mechanisms, including macrophage dysfunction, neutrophil dysfunction, and impairment of adaptive immune responses. One mechanism supported by evidence from animal models and human data, is the induction of heme oxygenase-1 in bone marrow, which impairs the ability of developing neutrophils to mount a competent oxidative burst. As a result, dysfunctional neutrophils become a new niche for replication of intracellular bacteria. Here we critically appraise and summarize the key evidence for mechanisms which may contribute to these very specific combinations of co-infections, and propose interventions to ameliorate this risk.
    Frontiers in Microbiology 06/2015; 6:666. DOI:10.3389/fmicb.2015.00666 · 3.94 Impact Factor
  • Source
    • "More recent community-based studies of the incidence of invasive bacterial infections in rural Gambia and Kenya have all documented a significant contribution to childhood morbidity and mortality in developing countries. One of the risk factors to develop invasive bacterial infections in Africa is Plasmodium falciparum malaria [Anthony et al., 2009; Scott et al., 2011; Bassat et al., 2009; Bronzan et al., 2007; Church et al., 2014]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In sub-Saharan Africa, concomitant occurrence of malaria and invasive infections with micro-organisms such as Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli and yeasts or fungi such as Candida albicans and Aspergillus fumigatus is common. Non-tuberculous mycobacteriosis caused by Mycobacterium chelonae has been recognized as a pulmonary pathogen with increasing frequency without effective therapy. Although less important, the high incidence of Trichophyton rubrum infections along with its ability to evade host defense mechanisms, accounts for the high prevalence of infections with this dermatophyte. Considering the treatment cost of both malaria and microbial infections, along with the level of poverty, most affected African countries are unable to cope with the burden of these diseases. In sub-Saharan Africa, many plant species are widely used in the treatment of these diseases which are traditionally diagnosed through the common symptom of fever. Therefore it is of interest to evaluate the antimicrobial activities of medicinal plants reported for their use against malaria/fever.
    Journal of Ethnopharmacology 03/2015; DOI:10.1016/j.jep.2015.03.008 · 3.00 Impact Factor
  • Source
    • "In addition, genetic variants will not be affected by reverse causality (Davey Smith & Ebrahim 2003). Epidemiological studies increasingly use Mendelian randomization to provide robust evidence of underlying causal mechanisms in a number of areas of health research including cardiovascular disease, cancer and mental health (Casas et al. 2005; Davey Smith et al. 2005; Benn et al. 2011; Scott et al. 2011; Interleukin-6 Receptor Mendelian Randomisation Analysis et al. 2012; Nordestgaard et al. 2012; Voight et al. 2012, Carslake et al. 2013). M a n u s c r i p t "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mendelian randomization methods, which use genetic variants as instrumental variables for exposures of interest to overcome problems of confounding and reverse causality, are becoming widespread for assessing causal relationships in epidemiological studies. The main purpose of this paper is to demonstrate how results can be biased if researchers select genetic variants on the basis of their association with the exposure in their own dataset, as often happens in candidate gene analyses. This can lead to estimates that indicate apparent “causal” relationships, despite there being no true effect of the exposure. In addition, we discuss the potential bias in estimates of magnitudes of effect from Mendelian randomization analyses when the measured exposure is a poor proxy for the true underlying exposure. We illustrate these points with specific reference to tobacco research
    Economics and human biology 01/2013; 13(100). DOI:10.1016/j.ehb.2013.12.002 · 2.46 Impact Factor
Show more